S44 The Type 1 Diabetic in Transition: Overcoming Obstacles to Effective Care

Program: Symposia
Clinical Session
Friday, March 6, 2015: 4:30 PM-6:00 PM
Room 30A (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by the Leona M. and Harry B. Helmsley Charitable Trust

Chair:
Irl B Hirsch, MD, University of Washington Medical Center, Seattle, WA

Disclosures:
IBH: Principal Investigator, Sanofi, Principal Investigator, Novo Nordisk, Principal Investigator, Haolzyme, Advisory Group Member, Abbott Laboratories, Ad Hoc Consultant, Roche Diagnostics, Ad Hoc Consultant, Valeritas.
4:30 PM
Carla Joy Greenbaum, MD, DCRP, Benaroya Res Institute, Seattle, WA
Nothing to Disclose: CJG
4:50 PM
Jill Weissberg-Benchell, PhD, Lurie Children's Hospital, Department of Psychiatry, Northwestern University Feinberg School of Medicine, Chicago, IL
Nothing to Disclose: JW
5:10 PM
Matthew Frederick Bouchonville, MD, Endocrinology, Diabetes, and Metabolism, University of New Mexico School of Medicine, Albuquerque, NM
Nothing to Disclose: MFB
See more of: Symposia